NCT06897111View on ClinicalTrials.gov

Implantation of Cartilage Mini-grafts Made From Donor Cells to Treat Chondral Lesions of the Knee

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 17, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2025

Conditions
Cartilage Repair
Interventions
BIOLOGICAL

Implantation of allogeneic cartilage mini-grafts (Allogeneic Cartibeads)

Implantation of allogeneic cartilage mini-grafts (Cartibeads) by minimally invasive surgery (arthroscopy or mini arthrotomy). Cartibeads should entirely fill the defect zone, followed by a thin layer of surgical glue (TISSEEL Fibrin Sealant).

Trial Locations (4)

1206

Center for Sports Medicine and Exercise, Hirslanden Clinique La Colline, Geneva

1211

Geneva University Hospitals (HUG), Geneva

6962

Ente Ospedaliero Cantonale (EOC), Lugano

8008

Balgrist University Hospital (BUH), Zurich

All Listed Sponsors
lead

Vanarix SA

INDUSTRY

NCT06897111 - Implantation of Cartilage Mini-grafts Made From Donor Cells to Treat Chondral Lesions of the Knee | Biotech Hunter | Biotech Hunter